Skip Navigation

Microbiology and Immunology

The Division of Microbiology and Immunology at the Emory National Primate Research Center provides leadership, resources and training to advance molecular and biological approaches to understand, prevent and treat infectious diseases.

By using nonhuman primates and rodents to study the progression of disease and to test new approaches to prevent and treat these infections in the most relevant animal models, Emory Primate Center (EPC) scientists provide the basic biomedical research that eventually will result in novel strategies for treatment and prevention of infectious diseases in humans. Current research in the Division of Microbiology and Immunology focuses on vaccines and treatments for HIV and AIDS; pathogenesis of immunodeficiency virus infections in nonhuman primates; comparative AIDS research; immunopathogenesis of hepatitis C virus; studies of novel candidate vaccines for Zika virus and group A Streptococccus infections.

One of the EPC’s foremost scientific goals is the development of a vaccine and a cure for HIV infection and AIDS through efforts that are catalyzed by the ERASE AIDS Program and the newly established ERASE HIV Martin Delaney Collaboratory. To this end, scientists in this division receive funding from the NIH through several large collaborative projects, including the Consortium for AIDS Vaccine Research in Nonhuman PrimatesThe Center for HIV/AIDS Vaccine Immunology (CHAVI-ID) and the Integrated Preclinical/Clinical AIDS Vaccine Development program (IPCAVD), as well funding from the Bill & Melinda Gates Foundation

Guido Silvestri, MD, an internationally recognized leader in AIDS research, serves as Division Chief. Core scientists for the division are Rama Rao Amara, PhDArash Grakoui, PhDR. Paul Johnson, MD, and Mirko Paiardini, PhD.

Division Researchers